Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	OLIENA Language recovery after stroke App | Video | PDF (278 pp) | Web

Inflammatory Bowel Diseases

Free Subscription 12.11.2018 1 Aliment Pharmacol Ther 2 Am J Gastroenterol 1 BMC Gastroenterol 1 Clin Gastroenterol Hepatol 1 Clin Res Hepatol Gastroenterol 1 Dig Dis 2 Inflamm Bowel Dis 7 J Crohns Colitis 1 PLoS One 6 Scand J Gastroenterol

Retrieve available abstracts of this week’s articles: HTML format Text format

Single Articles

Aliment Pharmacol Ther

1. PUREWAL S, Chapman S, Czuber-Dochan W, Selinger C, et al
   Systematic review: the consequences of psychosocial effects of inflammatory bowel disease on patients' reproductive health.
   Aliment Pharmacol Ther. 2018 Nov 8. doi: 10.1111/apt.15019.
   PubMed     Text format     Abstract available
   
   

   
   Am J Gastroenterol

2. CROSS RK, Langenberg P, Regueiro M, Schwartz DA, et al
   A Randomized Controlled Trial of TELEmedicine for Patients with Inflammatory Bowel Disease (TELE-IBD).
   Am J Gastroenterol. 2018 Nov 8. pii: 10.1038/s41395-018-0272.
   PubMed     Text format     Abstract available
   
   
3. NARULA N, Peerani F, Meserve J, Kochhar G, et al
   Correction: Vedolizumab for Ulcerative Colitis: Treatment Outcomes from the VICTORY Consortium.
   Am J Gastroenterol. 2018 Nov 2. pii: 10.1038/s41395-018-0401.
   PubMed     Text format     Abstract available
   
   

   
   BMC Gastroenterol

4. JIA Y, Li C, Yang X, Dong Z, et al
   CT Enterography score: a potential predictor for severity assessment of active ulcerative colitis.
   BMC Gastroenterol. 2018;18:173.
   PubMed     Text format     Abstract available
   
   

   
   Clin Gastroenterol Hepatol

5. AXELRAD JE, Olen O, Askling J, Lebwohl B, et al
   Gastrointestinal Infection Increases Odds of Inflammatory Bowel Disease in a Nationwide Case-Control Study.
   Clin Gastroenterol Hepatol. 2018 Oct 30. pii: S1542-3565(18)31025.
   PubMed     Text format     Abstract available
   
   

   
   Clin Res Hepatol Gastroenterol

6. HAN J, Liu T, Zhang M, Wang A, et al
   The relationship between inflammatory bowel disease and rosacea over the lifespan: A meta-analysis.
   Clin Res Hepatol Gastroenterol. 2018 Oct 30. pii: S2210-7401(18)30191.
   PubMed     Text format     Abstract available
   
   

   
   Dig Dis

7. DE VRIES JHM, Dijkhuizen M, Tap P, Witteman BJM, et al
   Patient's Dietary Beliefs and Behaviours in Inflammatory Bowel Disease.
   Dig Dis. 2018 Nov 2:1-9. doi: 10.1159/000494022.
   PubMed     Text format     Abstract available
   
   

   
   Inflamm Bowel Dis

8. VIADA BRIS JF, Velasco Rodriguez-Belvis M, de Lucas Collantes C, Aparicio Lopez C, et al
   Erratum to Ulcerative Colitis and Atypical Hemolytic-Uremic Syndrome: An Unusual But Potentially Life-threatening Complication.
   Inflamm Bowel Dis. 2018 Nov 8. pii: 5167023. doi: 10.1093.
   PubMed     Text format    
   
   
9. RAY G, Longworth MS
   Epigenetics, DNA Organization, and Inflammatory Bowel Disease.
   Inflamm Bowel Dis. 2018 Nov 8. pii: 5166720. doi: 10.1093.
   PubMed     Text format     Abstract available
   
   

   
   J Crohns Colitis

10. NYHOLM I, Hukkinen M, Koivusalo A, Merras-Salmio L, et al
    Long-term single center outcomes after proctocolectomy with ileoanal anastomosis for paediatric ulcerative colitis.
    J Crohns Colitis. 2018 Nov 3. pii: 5160018. doi: 10.1093.
    PubMed     Text format     Abstract available
    
    
11. DAI C, Jiang M, Huang YH
    Appendectomy for Therapy-Refractory Ulcerative Colitis Results in Pathological Improvement of Colonic Inflammation.
    J Crohns Colitis. 2018 Nov 5. pii: 5161247. doi: 10.1093.
    PubMed     Text format    
    
    
12. FEAGAN BG, Schwartz D, Danese S, Rubin DT, et al
    Efficacy of Vedolizumab in Fistulising Crohn's Disease: Exploratory Analyses of Data from GEMINI 2.
    J Crohns Colitis. 2018;12:621-626.
    PubMed     Text format     Abstract available
    
    
13. HOEKMAN DR, Stibbe JA, Baert FJ, Caenepeel P, et al
    Long-term Outcome of Early Combined Immunosuppression Versus Conventional Management in Newly Diagnosed Crohn's Disease.
    J Crohns Colitis. 2018;12:517-524.
    PubMed     Text format     Abstract available
    
    
14. VISSCHEDIJK MC, Spekhorst LM, Cheng SC, van Loo ES, et al
    Genomic and Expression Analyses Identify a Disease-Modifying Variant for Fibrostenotic Crohn's Disease.
    J Crohns Colitis. 2018;12:582-588.
    PubMed     Text format     Abstract available
    
    
15. BORREN NZ, Conway G, Garber JJ, Khalili H, et al
    Differences in Clinical Course, Genetics, and the Microbiome Between Familial and Sporadic Inflammatory Bowel Diseases.
    J Crohns Colitis. 2018;12:525-531.
    PubMed     Text format     Abstract available
    
    
16. PANES J, Vermeire S, Lindsay JO, Sands BE, et al
    Tofacitinib in Patients with Ulcerative Colitis: Health-Related Quality of Life in Phase 3 Randomised Controlled Induction and Maintenance Studies.
    J Crohns Colitis. 2018 Nov 8. pii: 5167345. doi: 10.1093.
    PubMed     Text format    
    
    

    
    PLoS One

17. EL-MATARY W, Deora V, Grover K
    Barriers to clinical research in children with inflammatory bowel disease: The patients' perspective.
    PLoS One. 2018;13:e0206965.
    PubMed     Text format     Abstract available
    
    

    
    Scand J Gastroenterol

18. KOMPEROD MJ, Sommer C, Mellin-Olsen T, Iversen PO, et al
    Persistent symptoms in patients with Crohn's disease in remission: An exploratory study on the role of diet.
    Scand J Gastroenterol. 2017 Nov 23:1-6. doi: 10.1080/00365521.2017.1397736.
    PubMed     Text format     Abstract available
    
    
19. SEGAL JP, Chan H, Collins B, Faiz OD, et al
    Biofeedback in patients with ileoanal pouch dysfunction: a specialist centre experience.
    Scand J Gastroenterol. 2018;53:665-669.
    PubMed     Text format     Abstract available
    
    
20. YAKYMENKO O, Schoultz I, Gullberg E, Strom M, et al
    Infliximab restores colonic barrier to adherent-invasive E. coli in Crohn's disease via effects on epithelial lipid rafts.
    Scand J Gastroenterol. 2018;53:677-684.
    PubMed     Text format     Abstract available
    
    
21. HOIVIK ML, Buer LCT, Cvancarova M, Warren DJ, et al
    Switching from originator to biosimilar infliximab - real world data of a prospective 18 months follow-up of a single-centre IBD population.
    Scand J Gastroenterol. 2018;53:692-699.
    PubMed     Text format     Abstract available
    
    
22. XIE D, Zhang Y, Qu H
    Crucial genes of inflammatory bowel diseases explored by gene expression profiling analysis.
    Scand J Gastroenterol. 2018;53:685-691.
    PubMed     Text format     Abstract available
    
    
23. SCHULZE H, Esters P, Hartmann F, Stein J, et al
    A prospective cohort study to assess the relevance of vedolizumab drug level monitoring in IBD patients.
    Scand J Gastroenterol. 2018;53:670-676.
    PubMed     Text format     Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Inflammatory Bowel Diseases is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: